NASDAQ:CMMB   Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd (NASDAQ:CMMB) My long position on this small bio play remains intact. On the technical side, the stock has been pulling back on low volume to test the breakout zone around the $20 area. If this zone is respected next week, I expect that the next rebound will push the price up to $27. Money flow has been very solid over the past days and the accumulation/distribution continues to be bullish, we just might be on our way to higher prices. NOTE: The company has a poster presentation scheduled for Wednesday at the International Liver Congress 2021 (EASL). Analysts' price target range consensus $43

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.